Comparative Pharmacology
Head-to-head clinical analysis: DISOMER versus ZYRTEC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DISOMER versus ZYRTEC.
DISOMER vs ZYRTEC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Selective dopamine D2 receptor antagonist; also blocks alpha-1 adrenergic, histamine H1, and muscarinic M1 receptors.
Selective histamine H1-receptor antagonist; inhibits histamine release from mast cells and basophils.
Adults: 1 mg orally once daily.
5-10 mg orally once daily; maximum 10 mg/day.
None Documented
None Documented
12–15 hours in adults with normal renal function; prolonged to 30–40 hours in severe renal impairment (CrCl <30 mL/min).
Terminal elimination half-life is approximately 8-11 hours in healthy adults, prolonged in renal impairment (e.g., up to 20 hours in moderate renal failure).
Renal: 80% as unchanged drug; biliary/fecal: 15% as metabolites; <5% unchanged in feces.
Cetirizine is primarily excreted unchanged in urine (approximately 70% renal elimination) and feces (about 10%).
Category C
Category C
Antihistamine
Antihistamine